Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Pratik is poised to propel the company to even greater heights.

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2024, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 977.20. On previous ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain ...

The Board of Directors of Gujarat Mineral Development Corporation Limited has appointed Dr. Sharvil Patel as an additional Independent Director on the Board w.e.f. 17th January 2025 for five years. Dr ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration ...